April 28th 2025
New research reveals GLP-1 receptor agonists may enhance sperm counts in overweight men.
Guideline adherence raises infection risk in diabetic penile prosthesis patients
December 3rd 2019Guideline-directed care often leads to better outcomes, but that’s not the case with the AUA’s antibiotic prophylaxis guidelines for diabetic patients undergoing primary penile prosthesis implantation. Authors of an ongoing study have found that adhering to the antibiotic prophylaxis guidelines results in a five-fold increased infection risk among diabetic penile prothesis patients, greatly increasing their risk for explantation.
New data point to statins’ potential for reducing prostate growth
November 27th 2019Results from analyses of data collected in the randomized, placebo-controlled Reduction by Dutasteride of prostate Cancer Events (REDUCE) trial point to a potential role for statins in attenuating age-related prostate enlargement.
Data from 18-year study support HoLEP’s efficacy
November 19th 2019Findings from an analysis of data collected prospectively over an 18-year period provide further evidence supporting guidelines that recommend holmium laser enucleation of the prostate as the size-independent gold standard for surgical management of BPH, say urologists from McGill University, Montreal.
Nomograms predict erectile function recovery
November 15th 2019A set of evidence-based nomograms for predicting recovery of erectile function after radical prostatectomy is now available, and the developers hope that surgeons will use these tools to provide prostate cancer patients with a more accurate personalized estimate of their sexual function outcome.
Study: ED questionnaire lacks crucial questions
November 6th 2019A patient-reported outcomes survey that is widely used to determine whether men are experiencing erectile dysfunction (ED) fails to ask three critical questions that could uncover whether men truly have ED and the extent to which they face challenges, researchers say.
New data point to statins’ potential for reducing prostate growth
November 1st 2019Results from analyses of data collected in the randomized, placebo-controlled Reduction by Dutasteride of prostate Cancer Events (REDUCE) trial point to a potential role for statins in attenuating age-related prostate enlargement.
Peyronie’s treatments costs, outcomes compared
October 16th 2019Researchers comparing cost and outcomes for surgery, collagenase clostridium histolyticum (CCH [Xiaflex]), and RestoreX traction therapy for Peyronie’s disease found traction is the most cost-effective option for achieving 20% or greater curvature improvement, but CCH or surgery might be more cost-effective and efficacious in specific scenarios.
Waterjet ablation shows same efficacy in small, large prostates
September 13th 2019Data from prospective clinical trials show that the efficacy of high-velocity waterjet ablation (Aquablation using the AquaBeam System) for improving BPH-related signs and symptoms is the same in patients with a large-to-very large prostate as in men with a small-to-moderate size gland, said Naeem Bhojani, MD, at the AUA annual meeting in Chicago.
What urologists can do to educate male patients
September 9th 2019Urologists should be open minded that more people are turning to the Internet for health care advice or services and should consider reaching patients where they live and work by implementing telemedicine, when it makes sense, or in their own online communications, according to Aaron Spitz, MD, of Orange County Urology Associates in California.
Urethral lift found safe, efficacious in real-world setting
August 12th 2019A study evaluating outcomes of the prostatic urethral lift (PUL; UroLift System) in clinical practice show that the efficacy and safety documented in the selected group of men enrolled in clinical trials is maintained across the broader spectrum of patients who present for treatment of symptomatic BPH in the real-world setting.
Shock wave therapy: ED cure or unproven treatment?
August 6th 2019Low-intensity extracorporeal shock wave therapy is a safe treatment for men with erectile dysfunction and might work to improve, or even cure, ED in some patients. But there remain important unanswered questions, including which patients are ideal candidates and which protocol and devices are best.
Post-prosthesis infection data alter conventional thinking
March 29th 2019"The observations that penile prosthesis surgical infections occurring early are frequently associated with anaerobic bacterial organisms and that these infections overall comprise diverse pathogens including fungal organisms fundamentally alter conventional thinking related to this topic area," writes Arthur L. Burnett, II, MD, MBA.
Data reveal timeline of post-IPP infections
March 29th 2019Isolated anaerobic organisms appear to occur most rapidly on average when infections occur following surgical intervention with an inflatable penile prosthesis (IPP), according to data presented at the 2018 AUA annual meeting in San Francisco.